Many tobacco users diagnosed with cancer wonder whether quitting matters. It does. In fact, persistent tobacco use is associated with a greater risk of recurrence (when the cancer comes back after treatment) as well as a greater risk of a new cancer developing. It has also been linked to shorter survival, an increase in treatment complications, and poorer quality of life.
In addition, quitting reduces symptoms associated with chemotherapy toxicity such as infection and problems involving the heart, breathing, or stomach. It can also improve your lung function, appetite, sleep, energy, and emotional well-being.
If you are a tobacco user who has received a cancer diagnosis and you are wondering, “Why bother quitting?” we encourage you to consider tobacco cessation as a way for you to become an active partner in your treatment and recovery.
The nicotine in tobacco products is very physically addictive. The US Food and Drug Administration has approved the use of several medicines to make it easier to stop using tobacco products by lessening the physical symptoms of withdrawal.
By temporarily supplying very small amounts of nicotine to the body through nicotine replacement therapies, such as gum, inhalers, and skin patches, it can become easier to cope with the cravings and symptoms of physically withdrawing from nicotine — helping free you to focus on the behavioral patterns of use that lead to quitting altogether.
Replacement products include the nicotine lozenge (Commit®), nasal spray (Nicotrol®), patch (NicodermCQ®, Nicotrol®, Habitrol®), gum (Nicorette®, Nicotrol®), and inhaler (Nicotrol®). Other prescription medicines help with withdrawal symptoms and cravings without the use of nicotine. These include bupropion SR pills (Zyban®, Wellbutrin SR®) and varenicline pills (Chantix®).
Studies show that using these medicines can double your chances of quitting for good. A tobacco treatment specialist at Memorial Sloan-Kettering will work with you and your doctor to decide which medicine might be right for you.
The amount of nicotine you get from nicotine replacement therapy products is very low. Some data from animal studies indicate that high amounts of nicotine (such as those found in cigarettes) can make cancer cells grow. Nonetheless, we recognize that taking nicotine replacement therapy for a short period of time is the most-effective method in the long run because it is a proven way to help people quit smoking.
Most people find it easy to gradually stop taking nicotine replacement therapies (NRT) after their recommended treatment period. In fact, the likelihood of long-term addiction to NRT is very low; the FDA regulates the amount of nicotine in these products at levels below what would be found in cigarettes. Also, NRT products supply nicotine to the body at a much slower rate than cigarettes, and also have a much lower risk of addiction.
Electronic cigarettes, or e-cigarettes, are not approved by the FDA to help people quit smoking. There is no scientific evidence that they are safe or effective.
Fortunately, for smokers who want to quit, there are approved medications for this use, as well as behavioral counseling — all of which are considered effective and safe. We advise people who are interested in the e-cigarette to consider using the Nicotrol® inhaler, which delivers an invisible nicotine vapor into the airway.
At Memorial Sloan-Kettering, we have a great deal of evidence that certain treatments work. We just need to get these treatments to work for you. Your best chance to permanently quit is to use nicotine replacement therapies along with a specialized, evidence-based behavioral treatment program.
Our tobacco treatment specialists will customize a plan designed to work specifically for you. It may take several attempts, but our specialists will ensure that you always receive treatment that gives you the best chances of quitting.
Insurance coverage for tobacco cessation services depends on your particular insurance plan. Most companies provide at least some level of mental health coverage, which is where you are most likely to find support for tobacco cessation services.
You can request a list of mental health providers from your health insurance plan or contact our Tobacco Cessation Program at 212-610-0507 to determine if we accept your insurance coverage.
I smoke cigars – isn’t that better than smoking cigarettes?
Many smokers believe that cigars are not harmful, but cigar use raises the risk of developing cancer of the mouth, lung, esophagus, and larynx and possibly leads to the development of chronic obstructive pulmonary disease (COPD).
When a person is trying to quit, the presence of other smokers can be challenging. We can help you identify social situations where you are likely to be tempted to smoke, and lay out a game plan.
We encourage you to make your home smoke-free so you can stay focused on your quitting goals. We find that it also helps to tell your friends and family that you’ve quit so they can be supportive of your efforts. You can also ask smokers you know to avoid smoking around you and refrain from giving you a cigarette, even if you ask.
These strategies are also good ways to encourage others to join you in quitting smoking.
Tobacco dependence is an addiction, and like most addictions, relapse is common. A person’s ability to quit depends upon a number of factors, including motivation to quit and adherence to and length of treatment.
Approximately 50 to 90 percent of smokers start smoking again within the first months of any treatment program — even in top programs offering the best evidence-based treatments available. In the Memorial Sloan-Kettering Tobacco Cessation Program, we offer only treatments that have been found through scientific studies to be effective and safe in helping smokers quit, and we offer longer-term counseling and support to reduce the chances of relapse.
In surveys, 90 percent of people treated through our program rate their satisfaction as “high,” and 96 percent say they would refer a friend or family member to the program. Significantly, approximately 45 percent of participants report being smoke-free at six months and 33 percent are smoke-free at 12 months. These quit rates compare very favorably with published research conducted with cancer patients and other medically ill smokers.